For the first time, TFRI is investing directly in cancer prevention, partnering with CIHR & CCS, and investing $10M to support projects that deepen our understanding of cancer development and advance early detection and risk reduction.
Learn more: tinyurl.com/a2untpve
Together, @cancersociety.bsky.social , its funding partners, these experts and their teams are turning groundbreaking research projects into a future where #cancer prevention is more proactive, more personalized and more accessible – allowing us to stop cancer before it starts.
Finally, CCS and @terryfoxresearch.bsky.social are funding Dr Alberto Martin, who is researching a common gut microbe to understand its link to #cancer. He and his team will study how dietary fibre and supplements affect the microbe and its connection to #ColonCancer and other growths in the colon.
In partnership with @terryfoxresearch.bsky.social , CCS is supporting Dr Vincent Fradet’s research into how #ProstateCancer and gut bacteria affect one another. This work may lead to new ways of predicting #cancer and may even lead to new treatments that can reduce the aggressiveness of the disease.
Co-funded by CCS and the CIHR Institute of Population and Public Health, Dr Aaron Goodarzi is studying #LungCancer risk factors. His team will research factors like indoor air #pollution, radon data and genetics to understand people’s exposure and risk – as well as these cancers’ economic costs.
In partnership with the CIHR Institute of Nutrition, Metabolism and Diabetes, CCS is supporting Dr Rachel Murphy’s research into whether ultra-processed foods cause #ColonCancer. The team will also study how these foods affect gut bacteria and how changes to the gut bacteria may affect #cancer.
In a third project co-funded by CCS and the CIHR ICR, Dr Christopher Maxwell and colleagues are studying whether a drug used to stop milk production after pregnancy can help prevent #BreastCancer in people with mutations that increase their risk – paving the way for a #ClinicalTrial.
Also in partnership with the CIHR ICR, CCS is funding Dr Luke McCaffrey and his team in understanding why some lesions become #BreastCancer and others don’t – allowing people who need #cancer treatment to receive it quickly and those who don’t to avoid unnecessary procedures and side effects.
In partnership with the CIHR Institute of #Cancer Research (ICR), CCS is supporting Dr Mark Basik’s work on better #BreastCancer screening for young women. Using AI-assisted imaging and genomics, they aim to understand which people would benefit from specialized screening or preventive treatment.
Up to 40% of #cancers are preventable – and new #research can help us stop cancer before it starts. That’s why, together, @cancersociety.bsky.social and partners are funding 7 teams committed to preventing cancer, reducing risk and improving early detection and diagnosis in Canada and worldwide.
An international collaboration to prevent #cancer!
Today @cancersociety.bsky.social , CIHR, @terryfoxresearch.bsky.social , the Japan Agency for Medical Research & Development, the Cancer Research Society & @biocanrx.bsky.social are investing $41.5 million to change the future of cancer prevention.
Today, Dr Demers and his team are updating the country’s most important data on workplace related #LungCancer to strengthen protections for workers in Canada now and in the future.
Learn more about his #research and see how you can help create a future without #cancer: bit.ly/460lZPe
@cancersociety.bsky.social -funded researcher Dr Paul Demers has spent more than 30 years uncovering how workplaces increase people’s risk of #cancer and transforming that evidence into meaningful, practical change. His #research has helped influence major policy decisions to help prevent cancer.
REMINDER: Deadline to submit abstracts for the Research Training Awards is February 18!
Learn more: cancer.ca/en/research/...
REMINDER: Call for nominations for @cancersociety.bsky.social Advisory Council on Research (ACOR).
We’re looking for #researchers and people with lived or living #cancer experience to join our ACOR and help guide #research programs and priorities.
Deadline is Feb 27.
Nominate here: is.gd/sMS7iN
@cancersociety.bsky.social -funded research is changing how people with #cancer are treated worldwide. We’re proud to see @myesmo.bsky.social #ClinicalPracticeGuideline update recommending structured exercise for people with #ColonCancer.
Learn more about this @cctg.bsky.social trial: is.gd/ojV6cY
Research trainees! Join our virtual IGNITE Workshop on Advocacy & Government Relations.
Learn how advocacy and storytelling drive impact in #cancer #research with @cancersociety.bsky.social Advocacy leaders Jasmine Brown & Dylan Buskermolen.
📅 Feb 6, 12 pm ET
Email research@cancer.ca to sign up.
Calling Canadian #ClinicalTrials investigators! You may be eligible for @cctg.bsky.social’s VISION Investigator Leadership Training. This 8-month program includes workshops, group discussions and personalized coaching.
Applications due January 30.
Learn more: www.ctg.queensu.ca/public/visio...
Day 1 (Jan 22) of the #HealthEquity in Cancer Research Symposium features workshops led by Drs Ambreen Sayani, Zhimeng Jia, Anna Pujadas Botey & Jagbir Kaur.
On Day 2 (Jan 28), #research teams across Canada will present their work in health equity followed by breakout rooms for group conversation.
Join our 2-part virtual Health Equity in Cancer Research Symposium! Explore how to apply #HealthEquity in #cancer #research and connect with teams across Canada. All team members are welcome!
📅 Jan 22 & 28, 2026 | 12:30–3:30 PM ET
Register here:
Day 1: is.gd/UAnaxj
Day 2: is.gd/lW0I7O
We have 8 #researcher vacancies and 3 for people with lived #cancer experience starting June 2026. Seeking members from diverse backgrounds, career stages, geography, age, gender, race and cancer experience.
👉 Nomination deadline: February 27 - 5 p.m. ET
Learn more: cancer.ca/en/research/...
CALL FOR NOMINATIONS: @cancersociety.bsky.social Advisory Council on Research
We’re looking for #researchers and people with lived or living #cancer experience to join our Advisory Council on Research (ACOR) and help guide #research programs and priorities.
Nominate here: is.gd/sMS7iN
ICYMI: Don’t forget to register and attend the information webinar if you plan to apply for this year's Research Training Awards – Master’s level.
🗓️Information webinar: January 14. Register here: is.gd/s75IVJ
Abstracts due: February 18.
Learn more: cancer.ca/en/research/...
Mark your Calendars! #CCTG is pleased to announce that the 2026 Annual Spring Meeting of Participants will be held April 24-26, 2026, at the Chelsea Hotel in Toronto. buff.ly/i4nddE9
A new round of @cancersociety.bsky.social Research Training Awards for master’s students is open for applications. A great opportunity for Black and Indigenous students looking for support, mentorship and training opportunities. Find out more now! cancer.ca/en/research/...
Research Training Awards recipients are driving breakthroughs of all kinds! We’re thrilled to support Dakota’s #research uncovering how time of day influences immune cell function – helping to pave the way for better lung #cancer treatments.
Important dates:
🗓️Information webinar: January 14, 2026.
Register here: is.gd/s75IVJ
🗓️Abstracts due: February 18, 2026
🗓️Full applications due: April 15, 2026
🗓️Results announced: August 2026
Learn more: cancer.ca/en/research/...
The RTA program aims to support growth, diversity and innovation in the next generation of #cancer researchers. It helps reshape the cancer #research landscape to be more equitable and inclusive while providing mentorship, training and engagement opportunities.
NEW FUNDING OPPORTUNITY: We’re pleased to announce that the @cancersociety.bsky.social Research Training Awards for master’s students are once again open for applications. This year, we invite Black and Indigenous trainees only to submit applications for the 2026 competition.
By testing potential new strategies to prevent, detect, treat and care for people affected by cancer, clinical trials are essential to driving research progress that can save and improve lives.
